Related Experiment Video
Updated: Feb 10, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Defective CSA-dependent granulopoiesis in patients with chronic drug-induced neutropenia
G Eliopoulos1, J Meletis, P Fessas
1Dept. of Medicine, University of Crete, School of Medicine, Greece.
Insights
Drug-induced neutropenia patients show decreased colony stimulating activity (CSA) from monocytes/macrophages, despite normal progenitor cells. This suggests a qualitative defect in CSA production contributes to impaired granulopoiesis.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Chronic neutropenia can be drug-induced, impacting white blood cell counts.
- Granulopoiesis, the production of granulocytes, is crucial for immune function.
- Colony stimulating activity (CSA) regulates the production of myeloid cells.
Purpose of the Study:
- To investigate the role of colony stimulating activity (CSA) and progenitor cells in drug-induced chronic neutropenia.
- To determine if defects in CSA production or progenitor cell numbers contribute to the condition.
Main Methods:
- Assayed colony stimulating activity (CSA) in bone marrow and peripheral blood.
- Quantified granulocyte-macrophage progenitor cells (GM-CFC) in bone marrow and peripheral blood.
- Compared these values in 17 patients with drug-induced neutropenia to normal controls.
Main Results:
- Leukocyte-derived and monocyte/macrophage-derived CSA were significantly decreased in neutropenic patients compared to controls.
- Bone marrow and peripheral blood GM-CFC levels were within normal limits.
- A qualitative defect in CSA production by monocytes/macrophages was identified.
Conclusions:
- Monocyte/macrophage dysfunction in CSA production is likely implicated in drug-induced neutropenia.
- This qualitative defect may contribute to the observed impaired granulopoiesis.
- Further research into monocyte/macrophage function in neutropenia is warranted.
Abstract:
Colony stimulating activity (CSA) and granulocyte-macrophage progenitor cells (GM-CFC) were assayed in the bone marrow and peripheral blood of 17 patients with drug-induced chronic neutropenia. Leukocyte-derived and monocyte/macrophage-derived CSA from the neutropenic patients was found to be significantly decreased compared to normal control. However, bone marrow and peripheral blood GM-CFC were within normal limits. These data suggest that in neutropenic patients monocyte/macrophages exhibit most likely a qualitative defect in CSA production, which may account at least in part, for the impaired granulopoiesis observed in drug-induced neutropenia.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Obese Patients
Drug Dependence

